Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Systematic literature review of secondary primary malignancies related to a CAR-T treatment in patients with multiple myeloma, lymphoma or leukemia.
Journal: Cancer treatment and research communications
Published: October 28, 2025
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 03, 2025
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR study.
Journal: British journal of haematology
Published: March 05, 2025
Persistent cytopenias after anti-BCMA CAR T-cell therapy are associated with reduced hematopoietic activity in posttreatment bone marrows.
Journal: American journal of clinical pathology
Published: April 08, 2024
Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients.
Journal: American journal of hematology
Published: August 24, 2023
Prospective Assessment of Humoral and Cellular Immune Responses to a Third COVID-19 mRNA Vaccine Dose Among Immunocompromised Individuals.
Journal: The Journal of infectious diseases
Published: April 06, 2023
Ciltacabtagene Autoleucel in Patients With Prior Allogeneic Stem Cell Transplant in the CARTITUDE-1 Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 21, 2023
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2-Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 28, 2023
Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.
Journal: Leukemia & lymphoma
Published: February 01, 2023
Last Updated: 09/26/2026